ÜBER DIESE EPISODE

Englisch
Vereinigte Staaten

TRANSKRIPT 🔗

VERGANGENE FOLGEN SUCHEN

Vorhandene Folgen von Pharma Sessions durchsuchen.

WEITERE EPISODEN IN DIESEM PODCAST

In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Dr. David Shulkin, President of Shulkin Solutions, to discuss what it actually takes to lead through a healthcare crisis at scale. Dr. Shulkin shares insights about the current state of U.S. public health, the intersection of pol…
In this episode of Pharma Sessions, host Jonathan Kaskey sits down for a second time with Dr. David Shulkin, President of Shulkin Solutions, to challenge the pharmaceutical industry’s fundamental approach to drug pricing and argue that outcomes-based contracting is the path forward for sustainable …
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Sonia Talwar, Senior Director of Scientific Communications and Medical Information in Hematology/Oncology at Pharmacosmos Therapeutics, to discuss how medical affairs can evolve from a reactive support function into a true strate…
 Here’s what keeps pharma leaders awake at night: 70% to 80% of ChatGPT usage is healthcare-related/ However, most pharmaceutical organizations still treat AI as a future consideration rather than an immediate competitive necessity. In this episode of Pharma Sessions, host Jonathan Kaskey is j…
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Eytan Abraham, the Chief Commercial and Technology Officer at Minaris Advanced Therapies, to dive into how pharma companies can choose the right CDMO partners, the future of cell and gene therapy manufacturing, and the hard-earne…
Rechtliche Hinweise: Der auf dieser Seite eingebettete Podcast und das Bildmaterial stammen von Jonathan Kaskey, das Eigentum seines Eigentümers ist und nicht mit Listen Notes, Inc. verbunden ist oder von diesen unterstützt wird.